Our website uses cookies. We and third parties we work with use cookies to collect information about your internet browsing activities to provide you relevant content and advertising on this and other websites, media and devices you use, and to understand your interests to improve the site. For more information on our use of cookies, please view our full Privacy Policy.
Two people exercising

The person shown in the image is not an actual patient

Personalised dosing with Mounjaro

The starting dose for Mounjaro is 2.5 mg, once weekly. After 4 weeks, your doctor may increase your dose to 5 mg, once weekly.1,2

Mounjaro KwikPen dosing schematic

Let your doctor know how you're doing on your current dose of Mounjaro during your next checkup

REPORTING SIDE EFFECTS AND PRODUCT COMPLAINTS

Please review the Consumer Medicine Information (CMI) leaflet for your multi-use KwikPen or single-use vial before taking Mounjaro. You can access the CMI online at www.lilly.com.au/en/products .

Side effects and product complaints should be reported. If your are worried about a side effect while taking a Lilly medicine, please contact your doctor. To report a side effect or a product complaint about a Lilly medicine, please call Lilly on: 1800 454 559. This information is brought to you by Lilly, the manufacturers of this medicine.

CaretDownFill

This medicine is subject to additional monitoring in Australia due to approval of an extension of indications. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.

Reference

  1. MOUNJARO® Consumer Medicine Information (single-use vial).
  2. MOUNJARO® Consumer Medicine Information (multi-use KwikPen).